Skip to content

Drug interactions

Insulin glargine-lixisenatide + Nateglinide

Severity: Moderate

Insulin glargine-lixisenatide and Nateglinide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nateglinide stimulates insulin secretion and adds to the glucose-lowering effect of insulin and lixisenatide, increasing hypoglycemia risk.

What this interaction means in plain words

Insulin glargine-lixisenatide and Nateglinide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Insulin glargine-lixisenatide belongs to Endocrine; Nateglinide belongs to Endocrine.

Evidence level: Moderate

Why it happens

Additive glucose lowering: nateglinide closes beta-cell potassium channels to promote insulin release.

What to do

Monitor blood glucose and reduce the dose of nateglinide or insulin if hypoglycemia occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Insulin glargine-lixisenatide and Nateglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Insulin glargine-lixisenatide with Nateglinide?

MediHelp rates the interaction as moderate. Insulin glargine-lixisenatide and Nateglinide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Nateglinide stimulates insulin secretion and adds to the glucose-lowering effect of insulin and lixisenatide, increasing hypoglycemia risk.

How serious is the interaction between Insulin glargine-lixisenatide and Nateglinide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose and reduce the dose of nateglinide or insulin if hypoglycemia occurs.

What other medicines interact with Insulin glargine-lixisenatide?

MediHelp also lists interactions of Insulin glargine-lixisenatide with, for example, Albiglutide, Chlorpropamide, Dulaglutide. The full list is on the Insulin glargine-lixisenatide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in